| The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain N Malek, M Kostrzewa, W Makuch, A Pajak, M Kucharczyk, F Piscitelli, ... Pharmacological research 111, 251-263, 2016 | 35 | 2016 |
| Molecular understanding of the activation of CB1 and blockade of TRPV1 receptors: implications for novel treatment strategies in osteoarthritis J Mlost, M Kostrzewa, N Malek, K Starowicz International journal of molecular sciences 19 (2), 342, 2018 | 27 | 2018 |
| Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of … A Pajak, M Kostrzewa, N Malek, M Korostynski, K Starowicz Journal of pain research, 1973-1989, 2017 | 24 | 2017 |
| CB2 agonism controls pain and subchondral bone degeneration induced by mono-iodoacetate: Implications GPCR functional bias and tolerance development J Mlost, M Kostrzewa, M Borczyk, M Bryk, J Chwastek, M Korostyński, ... Biomedicine & Pharmacotherapy 136, 111283, 2021 | 23 | 2021 |
| Sodium monoiodoacetate dose-dependent changes in matrix metalloproteinases and inflammatory components as prognostic factors for the progression of osteoarthritis M Bryk, J Chwastek, J Mlost, M Kostrzewa, K Starowicz Frontiers in Pharmacology 12, 643605, 2021 | 21 | 2021 |
| Alterations in anandamide synthesis and degradation during osteoarthritis progression in an animal model M Bryk, J Chwastek, M Kostrzewa, J Mlost, A Pędracka, K Starowicz International Journal of Molecular Sciences 21 (19), 7381, 2020 | 19 | 2020 |
| Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with … C Mugnaini, M Kostrzewa, M Bryk, AM Mahmoud, A Brizzi, S Lamponi, ... Journal of medicinal chemistry 63 (13), 7369-7391, 2020 | 19 | 2020 |
| Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer AM Mahmoud, M Kostrzewa, V Marolda, M Cerasuolo, F Maccarinelli, ... Pharmacological Research 189, 106683, 2023 | 18 | 2023 |
| Modeling acquired resistance to the second-generation androgen receptor antagonist enzalutamide in the TRAMP model of prostate cancer M Cerasuolo, F Maccarinelli, D Coltrini, AM Mahmoud, V Marolda, ... Cancer research 80 (7), 1564-1577, 2020 | 14 | 2020 |
| Biosynthesis of the Novel Endogenous 15-Lipoxygenase Metabolites N-13-Hydroxy-octodecadienoyl-ethanolamine and 13-Hydroxy-octodecadienoyl-glycerol by … AS Archambault, F Tinto, É Dumais, V Rakotoarivelo, M Kostrzewa, ... Cells 10 (9), 2322, 2021 | 13 | 2021 |
| Synthesis and molecular targets of N-13-hydroxy-octadienoyl-ethanolamine, a novel endogenous bioactive 15-lipoxygenase-derived metabolite of N-linoleoyl-ethanolamine found in … F Tinto, AS Archambault, É Dumais, V Rakotoarivelo, M Kostrzewa, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2021 | 9 | 2021 |
| New coumarin derivatives as cholinergic and cannabinoid system modulators S Montanari, M Allarà, L Scalvini, M Kostrzewa, F Belluti, S Gobbi, M Naldi, ... Molecules 26 (11), 3254, 2021 | 8 | 2021 |
| Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty … F Intranuovo, L Brunetti, P DelRe, GF Mangiatordi, A Stefanachi, ... Journal of Medicinal Chemistry 66 (1), 235-250, 2022 | 7 | 2022 |
| Modulation of endocannabinoid tone in osteoblastic differentiation of MC3T3-E1 cells and in mouse bone tissue over time M Kostrzewa, AM Mahmoud, R Verde, F Scotto di Carlo, F Gianfrancesco, ... Cells 10 (5), 1199, 2021 | 7 | 2021 |
| N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R) G Graziano, P Delre, F Carofiglio, J Brea, A Ligresti, M Kostrzewa, ... European Journal of Medicinal Chemistry 248, 115109, 2023 | 3 | 2023 |
| The Impact of JWH-133 on Articular Cartilage Regeneration in Osteoarthritis Via Metalloproteinase 13-Dependent Mechanism N Malek, J Borowczyk, M Kostrzewa, A Pawlowska, J Drukala, ... Cannabis and Cannabinoid Research 8 (5), 779-789, 2023 | 2 | 2023 |
| N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights … E Gianquinto, F Sodano, B Rolando, M Kostrzewa, M Allarà, ... Molecules 27 (23), 8152, 2022 | 2 | 2022 |
| Correction to Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Derivatives with … C Mugnaini, M Kostrzewa, M Bryk, AM Mahmoud, A Brizzi, S Lamponi, ... Journal of Medicinal Chemistry 63 (19), 11303-11303, 2020 | 2 | 2020 |
| Potencjał terapeutyczny układu endokanabinoidowego w leczeniu bólu ostrego i przewlekłego M Kostrzewa, K Starowicz Prace przeglądowe. Ból 16 (2), 29-37, 2015 | 2 | 2015 |
| Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-b]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands … C Mugnaini, M Kostrzewa, M Casini, P Kumar, V Catallo, M Allarà, ... Molecules 28 (13), 4958, 2023 | 1 | 2023 |
